Cardiac surgical implications of calcium dyshomeostasis in the heart

Annals of Thoracic Surgery

Volumn 61, Issue 4, 1996, Pages 1273-1280

  Meldrum, Daniel R ^a   Cleveland Jr , Joseph C ^a   Sheridan, Brett C ^a   Rowland, Robert T ^a   Banerjee, Anirban ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM BINDING PROTEIN;

ACTION POTENTIAL; HEART; HEART CONTRACTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART SURGERY; HOMEOSTASIS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ACTION POTENTIALS; CALCIUM; CALCIUM-BINDING PROTEINS; CARDIAC SURGICAL PROCEDURES; HEART; HOMEOSTASIS; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM;

EID: 0030115716     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(95)00952-3     Document Type: Review

References (61)

1. 2+ channels and ryanodine receptors in cardiac myocytes. Proc Natl Acad Sci USA 1995;92:121-5.
2. Hamby R. Primary myocardial disease, a prospective and hemodynamic evaluation in 100 patients. Medicine 1970;49: 55-78.
3. Grossmena W. Diastolic dysfunction and congestive heart failure. Circulation 1990;81(Suppl 3):1-7.
4. Knowlton A, Connelly C, Romo G, et al. Rapid expression of fibronectin in the rabbit heart following myocardial infarction with and without reperfusion. J Clin Invest 1992;89: 1060-8.
5. Alpert N, Gordon M. Myofibrillar adenosine triphosphate activity in congestive heart failure. Am J Physiol 1962;202: H940-6.
6. Unverferth D, Lee S, Et W. Human myocardial adenosine triphosphate activities in health and heart failure. Am Heart J 1988;115:139-46.
7. Schaper J, Froede R, Hein S, et al. Impairment of myocardial ultrastructural changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991;83:504-14.
8. Limas C, Olivari M-T, Goldenberg T, Benditt D, Simon A. Calcium uptake by cardiac sarcoplasmic reticulum in human dilated cardiomyopathy. Cardiovasc Res 1987;21:601-5.
9. Meldrum DR, Mitchell MB, Banerjee A, Harken AH. Cardiac preconditioning: induction of endogenous tolerance to ischemia-reperfusion injury. Arch Surg 1993;128:1208-11.
10. 1 adrenergic mechanism. Circ Res 1993;73:656-70.
11. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
12. Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 1994;74:555-64.
13. Brown JM, Harken AH, Sharefkin J. Recombinant DNA and surgery. Ann Surg 1990;212:178-86.
14. Rehring T, Brew E, Friese R, Banerjee A, Harken AH. Clinically accessible cell signalling: second messengers in sepsis and trauma. J Surg Res (in press).
15. Sheu SS, Blaustein MP. Sodium/calcium exchange and control of cell calcium and contractility in cardiac and vascular smooth muscles. In: Fozzard HA, ed. The heart and cardiovascular system. 2nd ed. New York: Raven Press, 1992: 903-43.
16. Barry WH, Bridge JHB. Intracellular calcium homeostasis in cardiac myocytes. Circulation 1993;87:1806-15.
17. Shen AC, Jennings RB. Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol 1972;67:417-40.
18. Steenbergen C, Fralix TA, Murphy E. Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res Cardiol 1993;88:456-70.
19. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol 1983;245: C1-14.
20. Morgan JP. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 1991;325:625-32.
21. Trautwein W, Heschler J. Regulation of cardiac L-type current by phosphorylation and G proteins. Annu Rev Physiol 1990;52:257-74.
22. Katz AM. Cyclic adenosine monophosphate effects on the myocardium: a man who blows hot and cold with one breath. J Am Coll Cardiol 1983;2:143-9.
23. Feldman MD, Copelas L, Guathmey JK, et al. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end stage heart disease. Circulation 1987;75:331-9.
24. Krause S, Hess ML. Characterization of cardiac sarcoplasmic reticulum dysfunction during short-term, normothermic, global ischemia. Circ Res 1984;55:176-84.
25. 2+ transport. Circ Res 1995;77:88-97.
26. + channels. Circ Res 1995;76:325-34.
27. 2+ activation of contraction as a consequence of reperfusion induced cellular calcium overload in ferret hearts. J Clin Invest 1987;79:950-61.
28. Shine KI, Douglas AM. Low calcium reperfusion of ischemic myocardium. J Mol Cell Cardiol 1983;15:251-60.
29. +. Am J Physiol 1990;258:H1025-31.
30. Go LO, Moschella MC, Watras J, et al. Differential regulation of intracellular calcium release channels during end-stage heart failure. J Clin Invest 1995;95:888-94.
31. Furuichi T, Yoshikawa S, Miyawaki A, et al. Primary structure and functional expression of the inositol 1,4,5-triphosphate-binding protein P400. Nature (Lond) 1989;342: 32-8.
32. Marks A, Tempst P, Chadwick C, et al. Smooth muscle and brain inositol 1,4,5-triphosphate receptors are structurally and functionally similar. J Biol Chem 1990;265:1-4.
33. Marks A, Tempst P, Hwang K, et al. Molecular cloning and characterization of the ryanodine receptor/junctional channel complex cDNA from skeletal muscle sarcoplasmic reticulum. Proc Natl Acad Sci USA 1989;86:8683-7.
34. 2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem 1990;265:13472-83.
35. Takeshima H, Nishimura S, Matsumoto T, et al. Primary structure and expression from complimentary DNA of skeletal muscle ryanodine receptor. Nature (Lond) 1989;339: 439-45.
36. Chadwick C, Saito A. Isolation and characterization of the inositol triphosphate receptor from smooth muscle. Proc Natl Acad Sci USA 1990;87:2132-6.
37. Lompre AM, Anger M, Levitsky D. Sarco(endo)plasmic reticulum calcium pumps in the cardiovascular system: function and gene expression. J Mol Cell Cardiol 1994;26: 1109-21.
38. Pegg W, Michalak M. Differentiation of sarcoplasmic reticulum during cardiac myogenesis. Am J Physiol 1987;252: H22-31.
39. Hoerter J, Mazet F, Vassort G. Perinatal growth of the rabbit cardiac cell: possible implications for the method of relaxation. J Mol Cell Cardiol 1981;13:725-40.
40. 2+-ATPase isoforms during ontogeny in the rat. J Mol Cell Cardiol 1994; 26:101-12.
41. 2+-ATPaSe and phospholamban mRNAs during rat heart development. Circ Res 1995;76:616-25.
42. 2+-ATPaSe and calsequestrin genes in rat heart during ontogenic development and aging. Circ Res 1991;69:1380-8.
43. Besse S, Assayagm P, Delcayre C, et al. Normal and hypertrophied senescent rat heart: mechanical and molecular characteristics. Am J Physiol 1993;265:H183-90.
44. 2+ ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res 1990;66:554-64.
45. 2+-ATPaSe and function of the sarcoplasmic reticulum during cardiac hypertrophy. Am J Physiol 1991;261:23-6.
46. 2+-ATPaSe gene expression in the human ventricle during end-stage heart failure. J Clin Invest 1990;85: 305-9.
47. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 1993;72:463-9.
48. Buttrick PM, Kaplan M, Leinwand LA, Scheuer J. Alterations in gene expression in the rat heart after chronic pathologic and physiologic loads. J Mol Cell Cardiol 1994;26:61-7.
49. Brilliantes A, Allen P, Takayashi T, Izumo S, Marks A. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res 1992;71:18-26.
50. Meldrum DR, Ayala A, Chaudry IH. Mechanism of diltiazem's immunomodulatory effects following hemorrhage and resuscitation. Am J Physiol 1993;265:C412-21.
51. Marban E, Koretsune Y, Corretti M, et al. Calcium and its role in myocardial cell injury during ischemia and reperfusion. Circulation 1989;80(Suppl 4):17-22.
52. Bolli R, Triana F, Jeroudi MO. Postischemic mechanical and vascular dysfunction (myocardial "stunning" and microvascular "stunning") and the effects of calcium-channel blockers on ischemia/reperfusion injury. Clin Cardiol 1989;12: III16-25.
53. Erbel R, Pop T, Meinertz T, et al. Combination of calcium channel blocker and thrombolytic therapy in acute myocardial infarction. Am Heart J 1988;115:529-38.
54. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
55. 1-selective adenosine analogues protects the heart against infarction. Circulation 1992;85:659-65.
56. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev 1990;70:761-845.
57. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation 1992;85:893-904.
58. 2+ paradox injury in rat heart: role of adenosine. Circ Res 1994;74:360-7.
59. Pogetti RS, Moore EE, Moore FA, Banerjee A. Gut and liver coordinated metabolic response following major torso injury. J Surg Res 1992;52:27-33.
60. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258:607-14.
61. 1 receptor. Am J Physiol 1995;268:C838-45.